Latest Research in Fatty Acid Research and Health

Top Research Topics in Fatty Acid Research and Health

• Fatty Acid Research and Health — 2 papers
• Adipokines, Inflammation, and Metabolic Diseases — 2 papers
• Pancreatitis Pathology and Treatment — 2 papers
• Chronic Obstructive Pulmonary Disease (COPD) Research — 2 papers
• Multiple Sclerosis Research Studies — 2 papers
• Genetic and Kidney Cyst Diseases — 2 papers
• Cystic Fibrosis Research Advances — 2 papers
• MicroRNA in disease regulation — 1 papers
• Connective tissue disorders research — 1 papers
• Hippo pathway signaling and YAP/TAZ — 1 papers

Highest-Cited Papers

1. Omic risk scores are associated with COPD-related traits across three cohorts (2 citations)
2. Keyora Antarctic Krill Oil EP-14: The Persistent Inflammation-Resolution Matrix: Phospholipid Omega-3 Across Metabolic-Adipose Inflammation, Resolution Biology, Vascular Residual Risk, and Response-Guided Escalation
3. Re‐evaluating variability of circulating miR‐122 in healthy volunteers: Implications for biomarker qualification in drug‐induced liver injury
4. Keyora Antarctic Krill Oil EP-14: The Persistent Inflammation-Resolution Matrix: Phospholipid Omega-3 Across Metabolic-Adipose Inflammation, Resolution Biology, Vascular Residual Risk, and Response-Guided Escalation
5. Non-coding regulatory variants in adolescent idiopathic scoliosis risk and pathogenesis
6. Alterations of Gene Expression and Signaling Pathway Activity in Venous Smooth Muscle Cells After Uremic Serum Exposure
7. Selected Cytokines and Matrix Metalloproteinases in Pathogenesis and Treatment of Multiple Sclerosis
8. Evaluating the consequences of childhood adiposity on the human plasma proteome at four timepoints across the lifecourse
9. Plasma proteomic profiling of septic shock and acute pancreatitis identifies shared signatures and disease-specific pathways
10. Sarsasapogenin Preserves Podocyte Integrity and Attenuates Renal Injury in Experimental IgA Nephropathy
11. Advancement and Challenges in Multiple Sclerosis: Understanding the Disease from Etiology to Treatment
12. Integrated Transcriptomics and Lipidomics Identify CES1-Mediated Maladaptive Lipolysis as a Key Target of Hyperlipidemic Acute Pancreatitis
13. Comprehensive analysis of non-synonymous single-nucleotide polymorphism of human TSC1 and TSC2 genes: An in silico approach
14. Monomethylation of cytosolic 5′-nucleotidase 1A affects its recognition by inclusion body myositis autoantibodies
15. Serum Levels of the Proinflammatory Cytokines IL-6, IL-16, IL-18, and IL-36 in Patients with Multiple Sclerosis from the Western Region of Saudi Arabia: Associations with Disease Duration and Disability
16. MIF Promoter Variant rs755622 (−173G/C) in Younger and Older Turkish Adults: An Exploratory Cross-Sectional Genetic and In Silico Analysis
17. Conserved water molecules shape the pathogenicity of missense variants in human proteins
18. ASSOCIATION BETWEEN SERUM RESISTIN AND DISEASE ACTIVITY IN TREATED RELAPSING–REMITTING MULTIPLE SCLEROSIS
19. The fibrocystin C-terminal domain inhibits Src/STAT3 signal induced cystogenesis of kidney epithelial cells.
20. Cellular Recovery and Therapeutic Rechallenge After Cancer Therapy-Induced Kidney Injury: Mechanistic Insights and Clinical Implications